Snowboarder Abe Teter Faces Aggressive Skin Cancer
The family of the former pro athlete has launched a fundraiser to help cover the costs of new, specialized medical treatments.
Updated on Sept. 30, 2026 in Cancer
Abe Teter, a 47-year-old former professional snowboarder, is seeking support for urgent medical expenses as he battles an aggressive form of skin cancer that began 19 years ago. His sister, Hannah Teter, initiated a crowdfunding effort on September 27, 2026, to help finance treatment aimed at preserving his remaining vision.
Why it matters
The fundraiser highlights the ongoing financial burdens associated with long-term, complex cancer care when standard interventions fail to stop disease progression. The goal is to secure access to new treatments before the cancer, which originated as basal cell carcinoma, poses further risks to his brain.
The case involves a 47-year-old patient who has undergone 19 years of varied interventions, including surgeries, chemotherapy, and immunotherapy. It remains unclear how effective the proposed new therapy will be in halting the progression of his aggressive, recurring skin cancer.
The players
Abe Teter
A 47-year-old former professional snowboarder currently undergoing long-term care for aggressive skin cancer.
Hannah Teter
The sibling of Abe Teter who established an online fundraiser to support his medical expenses.
The details
The patient's condition began as a basal cell carcinoma around his eye, a type of skin cancer that usually responds well to local excision but in this case has required multiple rounds of systemic and surgical intervention over nearly two decades. The disease has already resulted in the loss of his left eye, and the current clinical priority is preventing metastasis to the brain and protecting his remaining eyesight through new treatment protocols.
Timeline
Abe Teter rose to professional snowboarding prominence in the early 2000s.
The online fundraiser for his medical care was established on September 27, 2026.
Health Landscape
Most basal cell carcinomas are cured with simple surgical removal, making this long-term, refractory case an outlier in the clinical landscape. It highlights the specialized, often expensive, care pathways required for patients whose cancer evolves to resist conventional multi-modal therapies.
Patients with a history of skin cancer should discuss the necessity of regular, long-term dermatological surveillance with their primary physician, especially if they have experienced recurring or aggressive lesions. Early detection remains the most effective strategy to prevent complications that require extensive, multi-year medical intervention.
The takeaway
This case illustrates the critical importance of monitoring suspicious skin changes even years after an initial diagnosis. If you have a history of skin cancer, ensure you are maintaining a consistent screening schedule with a dermatologist to catch potential recurrences as early as possible.
Further reading
For more information on the management of persistent skin malignancies, visit Cancer.
